南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停

利用线粒体融合促进剂M1进行线粒体重塑,以治疗骨关节炎

Mitochondrial remodeling with mitochondrial fusion promoter M1 for osteoarthritis therapy

Zou Xiangqian, Ma Yibo, Yang Zhi, Zhang Renjie, Tao Christine, Zhang Guohua, Xu Chenyue, Liu Bingxin, Chen Changjian, Yang Liang

Journal:CELL BIOLOGY AND TOXICOLOGY

IF:5.7

DOI:10.1007/s10565-026-10242-8

PMID:

Published:2026-08-03

research field:分子生物学癌症研究结构生物学发育生物学细胞信号转导

Abstract

Osteoarthritis (OA) is closely associated with mitochondrial dysfunction, but whether mitochondrial dynamics restoration can serve as an effective therapeutic entry point remains unclear. This study investigated the mitochondrial fusion promoter M1 (MFPM1) as a modulator of mitochondrial dynamics in OA and explored its target-associated mechanism. Bioinformatic and transcriptomic analyses linked OA progression and MFPM1 activity to mitochondrial dynamics, oxidative stress, inflammatory activation, apoptosis, and extracellular matrix (ECM) homeostasis. In OA-like chondrocytes, MFPM1 restored the balance between DNM1L/DRP1-associated fission signaling and MFN2/OPA1-associated fusion machinery, accompanied by recovery of mitochondrial energy metabolism and redox homeostasis and attenuation of inflammatory and apoptotic injury. Target prediction, molecular docking, molecular dynamics simulation, and CETSA identified GSK3B as a prioritized MFPM1 target, while GSK3B overexpression weakened the mitochondrial and cartilage-protective effects of MFPM1, supporting its functional involvement. MFPM1 further preserved ECM homeostasis and alleviated OA progression. These findings identify mitochondrial dynamics remodeling as a mechanistic entry point for OA intervention and support MFPM1 as a mitochondria-centered therapeutic candidate.

本文使用的Yeasen产品

购物车
客服
转染试用